G-protein Coupled Receptors Market Report – Research, Industry Analysis Reports and Market Demands

Global G-protein Coupled Receptors Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

2 Company Profiles

3 Market Competition, by Players

3.1 Global G-protein Coupled Receptors Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
- 3.2.1 Market Share of G-protein Coupled Receptors by Company Revenue
- 3.2.2 Top 3 G-protein Coupled Receptors Players Market Share in 2025
- 3.2.3 Top 6 G-protein Coupled Receptors Players Market Share in 2025
3.3 G-protein Coupled Receptors Market: Overall Company Footprint Analysis
- 3.3.1 G-protein Coupled Receptors Market: Region Footprint
- 3.3.2 G-protein Coupled Receptors Market: Company Product Type Footprint
- 3.3.3 G-protein Coupled Receptors Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

4.1 Global G-protein Coupled Receptors Consumption Value and Market Share by Type (2021-2026)
4.2 Global G-protein Coupled Receptors Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

5.1 Global G-protein Coupled Receptors Consumption Value Market Share by Application (2021-2026)
5.2 Global G-protein Coupled Receptors Market Forecast by Application (2027-2032)

6 North America

6.1 North America G-protein Coupled Receptors Consumption Value by Type (2021-2032)
6.2 North America G-protein Coupled Receptors Market Size by Application (2021-2032)
6.3 North America G-protein Coupled Receptors Market Size by Country
- 6.3.1 North America G-protein Coupled Receptors Consumption Value by Country (2021-2032)
- 6.3.2 United States G-protein Coupled Receptors Market Size and Forecast (2021-2032)
- 6.3.3 Canada G-protein Coupled Receptors Market Size and Forecast (2021-2032)
- 6.3.4 Mexico G-protein Coupled Receptors Market Size and Forecast (2021-2032)

7 Europe

7.1 Europe G-protein Coupled Receptors Consumption Value by Type (2021-2032)
7.2 Europe G-protein Coupled Receptors Consumption Value by Application (2021-2032)
7.3 Europe G-protein Coupled Receptors Market Size by Country
- 7.3.1 Europe G-protein Coupled Receptors Consumption Value by Country (2021-2032)
- 7.3.2 Germany G-protein Coupled Receptors Market Size and Forecast (2021-2032)
- 7.3.3 France G-protein Coupled Receptors Market Size and Forecast (2021-2032)
- 7.3.4 United Kingdom G-protein Coupled Receptors Market Size and Forecast (2021-2032)
- 7.3.5 Russia G-protein Coupled Receptors Market Size and Forecast (2021-2032)
- 7.3.6 Italy G-protein Coupled Receptors Market Size and Forecast (2021-2032)

8 Asia-Pacific

8.1 Asia-Pacific G-protein Coupled Receptors Consumption Value by Type (2021-2032)
8.2 Asia-Pacific G-protein Coupled Receptors Consumption Value by Application (2021-2032)
8.3 Asia-Pacific G-protein Coupled Receptors Market Size by Region
- 8.3.1 Asia-Pacific G-protein Coupled Receptors Consumption Value by Region (2021-2032)
- 8.3.2 China G-protein Coupled Receptors Market Size and Forecast (2021-2032)
- 8.3.3 Japan G-protein Coupled Receptors Market Size and Forecast (2021-2032)
- 8.3.4 South Korea G-protein Coupled Receptors Market Size and Forecast (2021-2032)
- 8.3.5 India G-protein Coupled Receptors Market Size and Forecast (2021-2032)
- 8.3.6 Southeast Asia G-protein Coupled Receptors Market Size and Forecast (2021-2032)
- 8.3.7 Australia G-protein Coupled Receptors Market Size and Forecast (2021-2032)

9 South America

9.1 South America G-protein Coupled Receptors Consumption Value by Type (2021-2032)
9.2 South America G-protein Coupled Receptors Consumption Value by Application (2021-2032)
9.3 South America G-protein Coupled Receptors Market Size by Country
- 9.3.1 South America G-protein Coupled Receptors Consumption Value by Country (2021-2032)
- 9.3.2 Brazil G-protein Coupled Receptors Market Size and Forecast (2021-2032)
- 9.3.3 Argentina G-protein Coupled Receptors Market Size and Forecast (2021-2032)

10 Middle East & Africa

10.1 Middle East & Africa G-protein Coupled Receptors Consumption Value by Type (2021-2032)
10.2 Middle East & Africa G-protein Coupled Receptors Consumption Value by Application (2021-2032)
10.3 Middle East & Africa G-protein Coupled Receptors Market Size by Country
- 10.3.1 Middle East & Africa G-protein Coupled Receptors Consumption Value by Country (2021-2032)
- 10.3.2 Turkey G-protein Coupled Receptors Market Size and Forecast (2021-2032)
- 10.3.3 Saudi Arabia G-protein Coupled Receptors Market Size and Forecast (2021-2032)
- 10.3.4 UAE G-protein Coupled Receptors Market Size and Forecast (2021-2032)

11 Market Dynamics

11.1 G-protein Coupled Receptors Market Drivers
11.2 G-protein Coupled Receptors Market Restraints
11.3 G-protein Coupled Receptors Trends Analysis
11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

12.1 G-protein Coupled Receptors Industry Chain
12.2 G-protein Coupled Receptors Upstream Analysis
12.3 G-protein Coupled Receptors Midstream Analysis
12.4 G-protein Coupled Receptors Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology
14.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global G-protein Coupled Receptors market size was valued at US$ 1922 million in 2025 and is forecast to a readjusted size of US$ 3382 million by 2032 with a CAGR of 8.5% during review period.
G-protein coupled receptors (GPCRs) are seven-transmembrane receptor proteins located on the cell membrane and represent one of the most important and druggable target families in the human body. By sensing external stimuli such as hormones, neurotransmitters, chemokines, lipids, small-molecule metabolites, light signals, and odorants, GPCRs activate intracellular G proteins, β-arrestins, and related downstream signaling pathways. They regulate a wide range of physiological and pathological processes, including cardiovascular function, metabolism, the nervous system, immunity, endocrine signaling, respiration, digestion, sensory perception, and the tumor microenvironment. In industry research, GPCRs are not a conventional end product, but a platform-level research object spanning target discovery, drug screening, functional validation, structural biology, cell models, assay kits, and innovative drug development. GPCR-targeted therapeutics include agonists, antagonists, inverse agonists, allosteric modulators, and biased signaling modulators, making GPCRs one of the most mature, active, and still highly expandable target systems in global pharmaceutical innovation.The average gross profit margin of this product is 65%.
The core opportunity in the GPCR industry comes from the pharmaceutical sector’s continuous pursuit of highly druggable targets and the urgent need for new-mechanism therapies in major indications such as metabolic disease, obesity, diabetes, neuropsychiatric disorders, immune inflammation, pain, cardiovascular disease, and oncology. GPCRs are located on the cell surface, possess defined ligand-binding sites, and regulate actionable signaling pathways, making them important entry points for small-molecule drugs, peptide therapeutics, and emerging antibody-like technologies. Recent industry momentum around GLP-1, GIP, glucagon, S1P, chemokine receptors, and orphan receptors further demonstrates that GPCRs are not merely a mature target class with limited remaining value, but a core field capable of generating blockbuster products and platform-driven innovation. For CEOs and investors, the value of this sector lies not only in individual drugs, but also in the sustained project-generation capability created by high-throughput screening, structural biology, AI design, functional assays, and disease-model platforms.
The main challenges in GPCR research and development arise from dynamic receptor structures, diverse signaling pathways, broad tissue expression, and significant clinical translation risks. Many GPCRs can activate G proteins, β-arrestins, and other non-canonical pathways simultaneously, while different ligands may produce biased signaling, leading to differences in efficacy and safety. Some targets also face challenges related to homologous receptor selectivity, off-target effects, receptor internalization, tolerance, species differences, and long-term medication safety. For orphan receptors or emerging targets, endogenous ligands, disease relevance, and biomarkers may remain unclear, increasing R&D uncertainty. From a technical perspective, high-quality membrane protein expression, stable cell-line construction, cryo-EM structure determination, functional screening, and pharmacodynamic models all require long-term investment. Companies relying only on target concepts, without strong pharmacological validation, indication selection, and translational medicine capabilities, will find it difficult to navigate the full development cycle.
Downstream demand is evolving from traditional single-target drug discovery toward multi-mechanism, multi-modality, and precision-indication strategies. Pharmaceutical and biotech companies are increasingly focused on GPCR programs that can deliver differentiated efficacy, including multi-incretin receptor agonists, chemokine receptor modulators, CNS GPCRs, pain-related receptors, immune microenvironment regulatory receptors, and orphan GPCRs. CROs, drug discovery platforms, and research institutions continue to demand stable receptor-expressing cell lines, reporter gene assays, cAMP assays, calcium flux assays, β-arrestin recruitment assays, receptor internalization assays, and high-content imaging services. Future customers will no longer be satisfied with simple binding assays; they will value structural biology, AI-based molecular design, biased signaling analysis, in vitro and in vivo efficacy models, and clinical translation pathways. The GPCR value chain will move from “target screening” toward integrated competition across target, mechanism, molecule, and clinical evidence.
This report is a detailed and comprehensive analysis for global G-protein Coupled Receptors market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global G-protein Coupled Receptors market size and forecasts, in consumption value ($ Million), 2021-2032
Global G-protein Coupled Receptors market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global G-protein Coupled Receptors market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global G-protein Coupled Receptors market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for G-protein Coupled Receptors
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global G-protein Coupled Receptors market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, PerkinElmer, Eurofins DiscoverX, Charles River Laboratories, Cisbio Bioassays, Promega, Abcam, Selleck Chemicals, WuXi AppTec, GenScript, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
G-protein Coupled Receptors market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Class A GPCR
Class B GPCR
Class C GPCR
Other
Market segment by Research Application
Ligand Binding Assay
cAMP Assay
Calcium Flux Assay
Beta-arrestin Assay
Other
Market segment by Customer Segment
Pharmaceutical R&D
CRO Laboratory
Academic Research
Biotech Company
Other
Market segment by Application
Life Science Research
Drug Development and Target Validation
Animal Models and Preclinical Studies
Others
Market segment by players, this report covers
Thermo Fisher Scientific
PerkinElmer
Eurofins DiscoverX
Charles River Laboratories
Cisbio Bioassays
Promega
Abcam
Selleck Chemicals
WuXi AppTec
GenScript
Shanghai Medicilon
Merck
BD Biosciences
Molecular Devices
Qiagen
Corning
Discoverx
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe G-protein Coupled Receptors product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of G-protein Coupled Receptors, with revenue, gross margin, and global market share of G-protein Coupled Receptors from 2021 to 2026.
Chapter 3, the G-protein Coupled Receptors competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and G-protein Coupled Receptors market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of G-protein Coupled Receptors.
Chapter 13, to describe G-protein Coupled Receptors research findings and conclusion.

Buy now